BD wins FDA nod for breast biopsy, tissue removal system
January 15, 2026
BD (NYSE: BDX)+
announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
BD (NYSE: BDX)+
announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
IotaMotion announced today that it received FDA 510(k) clearance for expanded pediatric use of its iotaSoft insertion system.
A team of scientists from China has successfully created a miniature womb on a chip that mimics the complex environment of the human uterus. The research offers a new way to study the exact moment an embryo attaches to a mother’s body.
CMR Surgical announced today that it received CE mark and U.K. approval for its Versius surgical robot in pediatric surgery.
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
Two pioneering, clinically-led digital app solutions have won the Ripple Women’s Digital Health Challenge – a global innovation programme, delivered by Cogniss in partnership with the Health Innovation Network (the Network) and Amazon Web Services (AWS).
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Abbott (NYSE: ABT)+
announced today that it received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo Occluder.
According to a US pivotal study, the device’s sensitivity has been reported at more than 76% on all specimens.
The Anavi system treats polycystic ovary syndrome by delivering targeted radiofrequency energy to ablate ovarian tissue to re-initiate ovulatory cycles.